Loading
Latest filing published 17 Jun 2024 for ANAVEX LIFE SCIENCES CORP., €9,609. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Peter D.O. Donhauser, listed as board member, appears in our data through filings on Anavex Life Sciences Corp. shares, published by SEC (Form 4). Between 17 May 2021 and 14 June 2024, the trades on record add up to 2 filings.
Purchases make up the whole of the open-market record (2 purchases, €19k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2024 to date brings 1 purchase and no sales.
The newest entry dates from 17 June 2024: an open-market purchase of €9,609, in Anavex Life Sciences Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations